| Medical Condition | Asthma |
| Facility/Clinic | Accellacare – 1222 Medical Center Dr |
| Age | 12+ |
| Gender | Male & Female |
| Description | This is a clinical study of a drug called Tezepelumab (TEZSPIRE ®), which is already approved for use in severe asthma. We are looking for adults and adolescents from all ethnic groups to take part. Everyone who joins the PASSAGE study will receive Tezepelumab (TEZSPIRE) at no cast and will get advice and support from the study team. |
| Enrollment | Open |
| Patient Commitment Duration | 1 year |
| Number of visits in study | 15 |
| Patient Compensation | $75/visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.